Omega‐3 fatty acids supplementation for autism spectrum disorders (ASD)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Omega‐3 Fatty Acids Supplementation for Autism Spectrum Disorders (ASD)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438902/all/Paracetamol_versus_placebo_for_knee_and_hip_osteoarthritis_Edited__no_change_to_conclusions_. Accessed 29 March 2024.
Omega‐3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438902/all/Paracetamol_versus_placebo_for_knee_and_hip_osteoarthritis_Edited__no_change_to_conclusions_. Accessed March 29, 2024.
Omega‐3 fatty acids supplementation for autism spectrum disorders (ASD). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438902/all/Paracetamol_versus_placebo_for_knee_and_hip_osteoarthritis_Edited__no_change_to_conclusions_
Omega‐3 Fatty Acids Supplementation for Autism Spectrum Disorders (ASD) [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438902/all/Paracetamol_versus_placebo_for_knee_and_hip_osteoarthritis_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Omega‐3 fatty acids supplementation for autism spectrum disorders (ASD)
ID - 438902
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438902/all/Paracetamol_versus_placebo_for_knee_and_hip_osteoarthritis_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -